Updated results from the international phase III ALTTO trial (BIG
2–06/Alliance N063D)
- Citation:
- Eur J Cancer vol 148 287-296
- Year:
- 2021
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Long-Term-Followup
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 10
- Parents:
- 2689
- Children:
- None
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- Alvaro Moreno-Aspitia Eileen M. Holmes Christian Jackisch Evandro de Azambuja Frances Boyle David W. Hillman Larissa Korde Debora Fumagalli Miguel A. Izquierdo Ann E. McCullough Antonio C. Wolff Kathleen I. Pritchard Michael Untch Sébastien Guillaume Michael S. Ewer Zhimin Shao Sung Hoon Sim Zeba Aziz Georgia Demetriou Ajay O. Mehta Michael Andersson Masakazu Toi Istvan Lang Binghe Xu Ian E. Smith Carlos H. Barrios Jose Baselga Richard D. Gelber Martine Piccart-Gebhart
- Networks:
- Study
- NCCTG-N063D
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Early breast cancer, HER2, lapatinib, trastuzumab, adjuvant chemotherapy